| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $17.05 | $0.00 | Buy | 9 | 2026 |
#2 | GENB | United States | $12.91 | $0.00 | Strong Buy | 6 | N/A |
#3 | SUI | United States | $120.53 | $2,306,100,000.00 | Buy | 14 | 1996 |
#4 | PARR | United States | $57.19 | $2,443,066,000.00 | Buy | 6 | 2000 |
#5 | RSI | United States | $25.42 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#6 | INVA | United States | $21.70 | $217,217,000.00 | Buy | 5 | 2000 |
#7 | CARG | United States | $27.25 | $316,861,000.00 | Buy | 11 | 2017 |
#8 | EQT | United States | $54.47 | $8,644,211,000.00 | Buy | 21 | 1994 |
#9 | NFG | United States | $77.45 | $2,277,541,000.00 | Buy | 4 | 1997 |
#10 | SMG | United States | $56.97 | $3,016,500,000.00 | Buy | 6 | 2012 |
#11 | FLYW | United States | $14.61 | $623,025,000.00 | Buy | 14 | 2021 |
#12 | CVNA | United States | $63.65 | $20,322,000,000.00 | Buy | 24 | 2017 |
#13 | GMED | United States | $77.95 | $2,938,931,000.00 | Buy | 14 | 2012 |
#14 | ANIP | United States | $75.23 | $206,547,000.00 | Strong Buy | 5 | 1999 |
#15 | FAF | United States | $64.58 | $7,452,200,000.00 | Strong Buy | 4 | 2009 |
#16 | SHAK | United States | $55.53 | $1,445,306,000.00 | Buy | 26 | 2014 |
#17 | DEC | United States | $14.06 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#18 | TBPH | United States | $15.92 | $15,386,000.00 | Buy | 6 | 2013 |
#19 | PTCT | United States | $68.68 | $264,734,000.00 | Buy | 17 | 2006 |
#20 | GPOR | United States | $168.82 | $1,422,583,000.00 | Buy | 11 | 1998 |
#21 | KNSA | United Kingdom | $47.85 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#22 | EYE | United States | $16.68 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#23 | OOMA | United States | $16.88 | $114,490,000.00 | Strong Buy | 4 | 2015 |
#24 | VTR | United States | $79.05 | $5,833,980,000.00 | Buy | 13 | 2005 |
#25 | AORT | United States | $20.58 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#26 | KNTK | United States | $45.99 | $160,617,000.00 | Buy | 12 | 2017 |
#27 | CALX | United States | $38.50 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#28 | NTST | United States | $19.63 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#29 | APEI | United States | $52.39 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#30 | PSTL | United States | $22.09 | $95,823,000.00 | Strong Buy | 4 | 2018 |
#31 | SWX | United States | $85.73 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#32 | PFS | United States | $21.54 | $73,109,000.00 | Strong Buy | 4 | 2002 |
#33 | DCTH | United States | $10.33 | $0.00 | Strong Buy | 4 | 2015 |
#34 | NVST | United States | $22.40 | $2,566,500,000.00 | Buy | 13 | 2019 |
#35 | TRNO | United States | $64.10 | $476,383,000.00 | Buy | 12 | 2009 |
#36 | NMRK | United States | $13.97 | $3,294,024,000.00 | Buy | 5 | 2017 |
#37 | ALHC | United States | $14.25 | $3,948,719,000.00 | Buy | 8 | 2021 |
#38 | ARWR | United States | $72.55 | $16,142,321.00 | Strong Buy | 10 | 2009 |
#39 | OMER | United States | $10.16 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#40 | CTRE | United States | $38.03 | $476,393,000.00 | Buy | 10 | 2013 |
#41 | STOK | United States | $29.46 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#42 | ASMB | United States | $24.57 | $0.00 | Strong Buy | 5 | 2010 |
#43 | ANAB | United States | $51.24 | $234,603,000.00 | Buy | 12 | 2015 |
#44 | KRUS | United States | $44.15 | $282,763,000.00 | Buy | 9 | 2019 |
#45 | CCK | United States | $94.50 | $11,665,000,000.00 | Buy | 16 | 2003 |
#46 | MIRM | United States | $91.84 | $19,138,000.00 | Strong Buy | 13 | 2019 |
#47 | PECO | United States | $38.98 | $726,594,000.00 | Buy | 7 | 2010 |
#48 | AROC | United States | $34.21 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#49 | AVTX | United States | $13.80 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#50 | AMLX | United States | $13.20 | $380,786,000.00 | Strong Buy | 9 | 2021 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $200 to Buy (June 3, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.